Skip to main content
. 2020 Feb 10;11(8):2273–2282. doi: 10.7150/jca.38613

Figure 5.

Figure 5

Comparisons on white blood cells between healthy, tumor and tumor receiving invivoPen and PAM treatment in vivo at different testing time points.